Approximately 10-15% of cervical cancer patients are diagnosed during their reproductive years, including some who have not yet had children. Currently, with the continuous development of medical technology, new treatment methods and ideas have made possible the desire of many young female patients to both eradicate the disease and preserve their reproductive function. Current treatments to preserve the fertility of cervical cancer patients include cervical conization, radical hysterectomy and ovarian preservation with assisted conception techniques. Cervical conization is primarily indicated for young, infertile patients with in situ cancer. Radical hysterectomy was first proposed by Dargent in France in 1994. The scope of the operation includes pelvic lymphatic dissection, removal of part of the vagina and vault, part of the proximal main ligament and 80% of the cervix. Finally, the preserved cervix is ringed and the remaining cervical and vaginal sutures are articulated. Most of the current domestic and foreign literature reports that this technique is performed in some European and American countries, and it is carried out in Peking Union Medical College Hospital and Shanghai Cancer Hospital in China. However, this technique has strict indications, including young patients who desire fertility, no infertility factor, cervical tumor less than 2 cm, clinical stage IA2-IB1, squamous or adenocarcinoma, no metastasis found in regional lymph nodes, and no infiltration above the endocervix on colposcopy. Data reported a pregnancy rate of 37-61% within one year after surgery.